-
This indeed makes it much more difficult to pin down and see which physicians are using which drugs, but from their own internal sales information each drug company will have sales from drug stores, so the overall business from a pre set territory can be derived, so perhaps a new curve in Pharma marketing...
-
One more program to confuse us when needing a prescription, although I’m sure there is money to be saved here, but shoot I like the $4.00 or $10.00 generic prescriptions offered by others, no enrollment and no questions asked, simple. For the monthly fee, you might need to be a patient with some...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
11-06-2008
Filed under:
Filed under: Medically Related, Insurance, Pharma/FDA News, Other Items of Interest, drugs, healthcare, health insurance, Prescriptions, Medicare Part D, Aetna, Pharmacy, Costco
-
I will once more mention a potential change of paradigms here with educating the public. Each patient who took the drug is unique. Do we have any information on other drugs they were taking at the same time? Groups will continue to advise against the use until the full facts are known...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
10-31-2008
Filed under:
Filed under: Medically Related, Pharma/FDA News, Other Items of Interest, drugs, healthcare, Pharma, PHR, FDA, Marketing, paradigms, personal heatlh records
-
Even folks with money and in high positions have problems getting access to cancer drugs, as you can read below, and this was not an issue of not being able to afford the medication. When you read items as such, it makes you stop and think how precious life and healthcare really is. BD ...
-
A qualified system is not faxing! Many offices who are set up with an EMR or EHR are already covered and are either set up and ready to go or have the capabilities. For those who are not, there’s a permanent link on this page to NEPSI, the free e-prescribing initiative where you can sign...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
10-31-2008
Filed under:
Filed under: Medically Related, Technology, Insurance, Pharma/FDA News, drugs, healthcare, medicare, health insurance, Physicians, Prescriptions, e-prescribing
-
$9.99 for 90 days with enrollment with the Health Savings Pass CVS becomes the latest retail drug chain to jump on the bandwagon, pretty close in comparison, except you need to join the Health Savings Plan. The plan is primarily created for cash patients but anyone can benefit so if you have a...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
10-31-2008
Filed under:
Filed under: Medically Related, Insurance, Pharma/FDA News, drugs, PHR, Google Health, Prescriptions, Generic Drugs, Personal Health Records, HealthVault, CVS, Discounts, Minute Clinic
-
The company has formed a “strategic partnership” with inVentiv Health , who does a lot of outsourcing for big Pharma, earlier this year, so perhaps some the sales and marketing slated for sales will be moving in this direction. Merck is not the only company investigating and pursuing this direction...
-
Reports of four experimental drugs held up at the FDA emerged in the first two days of this week. “ There’s almost certainly a bit of coincidence at work here, but it also seems to be one more sign of the tough safety climate at the agency these days .” Below are the 4 drugs. No doubt the...
-
I keep a constant listing here with links to the $4.00 prescriptions as well as a link to Needy Meds. Anyone can take advantage of the $4.00 prescriptions and with Needy Meds there are guidelines to meet as far as income. The $4.00 Kroger generic link is one of the heaviest hit posts on this blog...
-
The company has 6 months to get the shares up above $1.00 or it goes to the junk category and off the big board. Drug stores are feeling the pinch of the economic slow down, depending on where the stood financially before hand, has an effect on where they are today. Granted Rite Aid had some...
-
Some of the duties will be outsourced, but under the control of a local office, and portions of this provision will need an act of Congress, so I might guess now’s the time, or after the election maybe to tackle this issue. I would also like to see labels on every product stating the city, origin...
-
I wonder if all the name brand companies will one day have nothing but generics? (grin). There’s always this interesting topic too, biosimilars. “Because biosimilars aren't exact duplicates of the original drugs, they don't violate the original drug's patent , enabling legal distribution...
-
Whistle blowers today seem to be playing a role in the move towards transparency in more ways than one, not to mention the bounty that could be there if a case goes to court and wrongdoing is found to be the case. BD A New Jersey arbitrator ruled that a former Amgen sales rep can proceed with a...
-
The UK continues to say “no” to cancer drugs due to price. If you stop and look at the prices for cancer drugs, something along the line here is going to need to balance soon. It is great and wonderful to have the R and D and great breakthroughs that are occurring almost daily, but what good does...
-
The costs of cancer treatment and associated drugs is rising as we all know. We are pouring money into R and D as fast as we can, and yes that does cost money, but insurers are making it hard to get insurance coverage and somewhere along the line you need to have a drug that is affordable as well...